Salveen Richter analyst GOLDMAN SACHS

Currently, out of the existing stock ratings of Salveen Richter - 87 which are a Hold (33.21%), 155 which are a Buy (59.16%), 20 which are a Sell (7.63%)

Salveen Richter

Work Performance Price Targets & Ratings Chart

Analyst Salveen Richter works at GOLDMAN SACHS and is covering Healthcare, Technology sectors with 460 price targets and ratings displayed on 47 stocks.

Salveen Richter's average stock forecast success ratio is 65.38% with an average time for price targets to be met of 218.47 days.

Most recent stock forecast was given on INCY, yte at 22-Nov-2023.

Wall Street Analyst Salveen Richter

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ACOR Acorda Therapeutics ADPT Adaptive Biotechnologies AGIO Agios Pharmaceuticals ALLO Allogene Therapeutics ALNY Alnylam Pharmaceuticals BLUE bluebird bio BMRN BioMarin Pharmaceutical BPMC Blueprint Medicines CRSP CRISPR Therapeutics AG DNLI Denali Therapeutics DTIL GWPH ICPT Intercept Pharmaceuticals INCY yte KRTX Karuna Therapeutics MDGL Madrigal Pharmaceuticals MRNA Moderna MRTX Mirati Therapeutics NTLA Intellia Therapeutics RETA Reata Pharmaceuticals SAGE Sage Therapeutics SANA SGEN Seattle Genetics SRPT Sarepta Therapeutics TSHA Taysha Gene Therapies VRTX Vertex Pharmaceuticals ARWR Arrowhead Pharmaceuticals ATRA Atara Biotherapeutics BIIB Biogen CNTA PASG Passage Bio REGN Regeneron Pharmaceuticals RXRX GILD Gilead Sciences RDUS Radius Health AMGN Amgen QURE uniQure N.V TSVT ADSK Autodesk FOLD Amicus Therapeutics IONS Ionis Pharmaceuticals LYEL ONCE RARE Ultragenyx Pharmaceutical RCUS Arcus Biosciences SLDB Solid Biosciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

35

$12.4 (54.87%)

20

29 days ago

4/7 (57.14%)

$1.01 (4.50%)

32

Hold

31

$8.4 (37.17%)

30

1 months 2 days ago

15/17 (88.24%)

$4.69 (20.15%)

193

Buy

33

$10.4 (46.02%)

33

1 months 2 days ago

10/15 (66.67%)

$9.01 (41.66%)

235

Buy

42

$19.4 (85.84%)

39

1 months 2 days ago

9/14 (64.29%)

$8.64 (37.89%)

235

Hold

32

$9.4 (41.59%)

29

1 months 25 days ago

5/6 (83.33%)

$0.98 (5.51%)

26

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Salveen Richter is most bullish on?

Potential upside of $151.11 has been obtained for MRNA (MODERNA)

Which stock is Salveen Richter is most reserved on?

Potential downside of -$1.47 has been obtained for CNTA

What Year was the first public recommendation made by Salveen Richter?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart